Cellscript, LLC
Madison, WI, US· latest recorded location
CELLSCRIPT, LLC is named on 14 US grants and 21 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 14
- Published applications
- 21
- Inventors
- 19
- Granted in 2026 so far
- 0
- Most recent grant
- 13 Aug 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 3 | 2 |
| 2013 | 0 | 1 |
| 2014 | 2 | 5 |
| 2015 | 3 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 35 documents
- C12NMicroorganisms or enzymes33
- C12YEnzymes18
- A61KMedicines and medical preparations17
- C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition15
- C07KPeptides9
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9
- Y02ATechnologies for adaptation to climate change8
- A61PTherapeutic uses of medicines7
- Y10TTechnical subjects covered by former us classification2
- C40BCombinatorial chemistry1
Recent patents
- Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect13 Aug 2024US 12,059,479 B2
- Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect5 Oct 2021US 11,135,314 B2
- Inhibition of innate immune response6 Oct 2020US 10,793,831 B2
- Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect12 Feb 2019US 10,201,620 B2
- Inhibition of innate immune response9 Jan 2018US 9,862,926 B2
- Analysis of mrna 5' capping efficiency27 Aug 2026US 2026/0250747 A1
- Assay of rna poly(a) tail length27 Aug 2026US 2026/0250762 A1
- Making and using in vitro synthesized ssrna for introducing into mammalian cells to induce a biological or biochemical effect7 Aug 2025US 2025/0249128 A1
- Compositions, systems, and methods for generating gene-edited cells6 Jun 2024US 2024/0181005 A1
- Making and using in vitro-synthesized ssrna for introducing into mammalian cells to induce a biological or biochemical effect18 Aug 2022US 2022/0257795 A1
Most cited
By later US patents
- Kits and methods for generating 5′ capped RNA108US 8,846,348 B22014
- Compositions and methods for reprogramming eukaryotic cells103US 8,808,982 B22014
- Synthesis of tagged nucleic acids72US 8,039,214 B22011
- Synthesis of tagged nucleic acids68US 8,329,887 B22012
- Selective terminal tagging of nucleic acids57US 8,304,183 B22012